30 results
8-K
EX-99.1
ANNX
Annexon Inc
4 Mar 24
Regulation FD Disclosure
5:25pm
Love Annexon: Overview and Commitment to GBS 10:00-10:05am President & CEO Lisa Butler GBS Patient Voice 10:05-10:15am Executive Director, GBS | CIDP … and Peripheral Nerve Society Annual Meetings 2021-2022.
Annexon Has a Deep-Rooted History and Commitment to GBS Aligned With Our Mission Strong Scientific
8-K
EX-1.1
ANNX
Annexon Inc
21 Dec 23
Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
4:09pm
into or exchangeable for, any shares of capital stock or other equity interest in the Company or any of its subsidiaries, or any contract, commitment
8-K
EX-10.1
j1n5n4oue0zj5k6 ze
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-99.1
2fdx9j
4 Oct 21
Departure of Directors or Certain Officers
4:06pm
10-K
bggx1
25 Mar 21
Annual report
7:16am
10-Q
0pepgy x9p6
8 Sep 20
Quarterly report
5:18pm
424B4
zlv0a uv5ru73
24 Jul 20
Prospectus supplement with pricing info
5:15pm
S-1/A
b5v4sm
20 Jul 20
IPO registration (amended)
6:07am
S-1/A
EX-1.1
ufo wbsk0q6
20 Jul 20
IPO registration (amended)
6:07am
S-1/A
EX-3.1
qne 4lhn97
20 Jul 20
IPO registration (amended)
6:07am
S-1
EX-10.2
zpygz 0x3dllo
2 Jul 20
IPO registration
12:00am